First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids

MLA

Endri Karaj, et al. “First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids.” Journal of Medicinal Chemistry, vol. 65, Oct. 2022, pp. 14764–91. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c01276.

APA

Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, Radhika A. Koranne, Joseph R. Knoff, Antonisamy William James, Yu Fu, Lauren N. Kotsull, Mary Kay Pflum, Zahoor Shah, William R. Taylor, & L. M. Viranga Tillekeratne. (2022). First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids. Journal of Medicinal Chemistry, 65, 14764–14791. https://doi.org/10.1021/acs.jmedchem.2c01276

Chicago

Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, Radhika A. Koranne, Joseph R. Knoff, Antonisamy William James, Yu Fu, et al. 2022. “First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids.” Journal of Medicinal Chemistry 65 (October): 14764–91. doi:10.1021/acs.jmedchem.2c01276.